Insider · CIK 0002048095
Robert J. Ciaruffoli
Files at MDCX (Medicus Pharma Ltd.). First filing -, latest -.
In brief
Robert J. Ciaruffoli files SEC Form 4 as director at MDCX (Medicus Pharma Ltd.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Robert J. Ciaruffoli has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | MDCX Medicus Pharma Ltd. | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 4, 2026 |
| Mar 30, 2026 | MDCX Medicus Pharma Ltd. | AGrant or award Stock Option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Apr 1, 2026 |
| Dec 16, 2025 | MDCX Medicus Pharma Ltd. | AGrant or award Stock Option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Dec 18, 2025 |
| Jul 22, 2025 | MDCX Medicus Pharma Ltd. | AGrant or award Stock Option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Jul 24, 2025 |
Questions about Robert J. Ciaruffoli
Answered from the filings on this page, as of the latest one.
Is Robert J. Ciaruffoli buying or selling?
Robert J. Ciaruffoli has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Robert J. Ciaruffoli's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert J. Ciaruffoli has 0.
Where does Robert J. Ciaruffoli file Form 4?
Robert J. Ciaruffoli has filed Form 4 at MDCX (Medicus Pharma Ltd.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.